查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球溶酵素體貯積症治療市場規模、份額和行業趨勢分析報告：2022-2028 年各疾病類型、治療類型、最終用戶和地區的展望和預測
市場調查報告書
商品編碼
1126409

全球溶酵素體貯積症治療市場規模、份額和行業趨勢分析報告：2022-2028 年各疾病類型、治療類型、最終用戶和地區的展望和預測

Global Lysosomal Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type, By Type of Therapy By End User, By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 230 Pages | 訂單完成後即時交付

價格

到 2028 年，溶酵素體貯積病治療的全球市場規模預計將達到 110 億美元，在預測期內以 6.3% 的複合年增長率增長。

溶酵素體水解酵素的突變與細胞大分子的降解有關，是導致 LSD 的主要原因，佔三分之二以上的病例。因此，LSD 的貯藏產物中存在多種生化來源，包括脂質、糖原、粘多醣和糖蛋白。除 X 連鎖法布裡病、達農病和亨特病外，所有 LSD 均為常染色體隱性遺傳。

LSD，單獨或作為多系統疾病的一部分，在臨床上具有高度異質性，影響大多數器官。雖然溶酵素體酵素是看家基因，在大多數細胞中都有表達，但它們作用的組織分佈並不均勻，這使得很難確定哪些組織受到影響。我已經決定了。

COVID-19 影響分析

COVID-19 公共衛生危機正在影響幾乎所有行業。 COVID-19 的爆發影響了多個行業，尤其是衛生和製藥行業，因為冠狀病毒危機席捲全球，迫使醫護人員將大部分資金用於抗擊 COVID-19。這導致對 COVID-19 的需求顯著減少整個領域溶酵素體貯積病藥物的市場規模。感染風險是導致溶酵素體貯積症患者在醫院延誤治療的主要因素。 COVID-19 的爆發將減緩全球溶酵素體貯積病治療市場的發展，從而損害其 2022 年以後的市場價值。

市場增長因素

溶酵素體貯積病的患病率正在上升

酵素替代療法市場的主要驅動力是擴大用於診斷和治療溶酵素體貯積病的藥物開發的研發。溶酵素體貯積病患病率的上升將是加速市場增長率的關鍵因素。美國國家生物技術信息中心發布的一份報告顯示，2020 年 1 月白人男性社區法布裡病的患病率為 1:17,000 至 1:117,000。非典型表現與女性約 1:6000 至 1:40,000 和男性約 1:1000 至 1:3000 相關，而男性 1:22,000 至 1:40,000 攜帶經典的法布裡突變。

孤兒藥開發的財政激勵措施以收回研發成本

影響溶酵素體貯積症藥物市場增長率的一個重要因素是醫療費用的增加（這有助於基礎設施的發展）。各政府機構為加強醫療基礎設施而增加資金的努力將進一步影響市場動態。此外，由於早期診斷接受率的提高和政府提高認識的計劃增加，溶酵素體貯積病治療市場預計將增長。與此相伴的是，政府慈善項目的擴大和可支配收入的增加將加速市場的擴張。

市場製約因素

幹細胞療法存在很多問題

移植後不久出現的許多問題是由於藥物或輻射立即破壞了骨髓。在某些情況下，調節程序本身可能會產生意想不到的後果。患者可以從移植團隊獲得支持以管理副作用。大多數可以管理以使患者感覺更好，有些可以預防。這不是一個完整的列表，因此請告知您的醫生或移植團隊您遇到的任何問題或調整。

按疾病類型劃分的前景

根據疾病類型，溶酵素體貯積病治療市場分為戈謝病、法布裡病、龐貝綜合徵、粘多醣貯積症等。 2021 年，戈謝病部門在溶酵素體貯積病治療市場中獲得了最高的收入份額。這是因為戈謝病患病率的上升是主要的市場驅動力。此外，該領域的增長將受到強大的批准藥物和正在開發的新療法的推動。

按治療類型劃分的前景

溶酵素體貯積病治療市場按治療類型分為酵素替代療法、幹細胞療法、底物減少療法等。幹細胞治療部門將在 2021 年在溶酵素體貯積病治療市場中獲得可觀的收入份額。 LSD 通過分泌再攝取溶酵素體水解酵素進行交叉校正的能力使其成為乾細胞治療非常有吸引力的目標，而骨髓同種異體移植是第一個應用於 LSD 的特定治療方式。

最終用戶視角

溶酵素體貯積病治療市場按最終用戶細分為醫院、診所等。由於越來越多的人因溶酵素體貯積病尋求住院治療，醫院部門在 2021 年的溶酵素體貯積病治療市場中獲得了最高的收入份額。醫院正在使用這些技術來滿足日益增長的需求，以經濟高效的方式簡化其臨床操作。醫院是人們可以通過熟練的醫務人員、行政人員、醫療設備等獲得醫療服務的設施。

區域展望

溶酵素體貯積病治療市場按北美、歐洲、亞太地區和拉美地區進行了分析。 2021年，北美分部在溶酵素體貯積病治療市場中佔據了最大的收入份額。歸因於北美溶酵素體貯積病的高患病率。新醫學療法的發展、診斷技術的進步以及公眾對溶酵素體貯積病的認識不斷提高，正在推動這一市場的擴張。各國已使用不同的策略來滿足其處理這一特殊高成本問題的需要。

內容

第一章市場範圍和研究方法

  • 市場定義
  • 目的
  • 市場規模
  • 細分
    • 全球溶酵素體貯積病治療市場，按疾病類型
    • 全球溶酵素體貯積病治療市場，按治療類型
    • 全球溶酵素體貯積病治療市場，按最終用戶分類
    • 按地區分列的全球溶酵素體貯積病治療市場
  • 調查方法

第 2 章市場概述

  • 簡介
    • 概覽
      • 市場構成和情景
  • 影響市場的主要因素
    • 市場驅動力
    • 市場製約因素

第 3 章。全球溶酵素體貯積病治療市場：按疾病類型分類

  • 全球戈謝病市場：按地區
  • 全球法布裡病市場：按地區
  • 全球粘多醣貯積症市場：按地區劃分
  • 龐貝綜合症全球市場：按地區
  • 按地區劃分的其他全球市場

第 4 章全球溶酵素體貯積病治療市場：按治療類型

  • 全球酵素替代療法市場：按地區劃分
  • 全球底物減少療法市場：按地區劃分
  • 全球幹細胞治療市場：按地區
  • 按全球地區劃分的其他市場

第 5 章溶酵素體貯積病治療的全球市場：按最終用戶分類

  • 全球醫院市場：按地區
  • 全球診所市場：按地區
  • 按地區劃分的世界其他市場

第 6 章。全球溶酵素體儲存藥物市場：按地區劃分

  • 北美
    • 北美溶酵素體儲存藥物市場：按國家/地區分類
      • 美國
      • 加拿大
      • 墨西哥
      • 北美其他地區
  • 歐洲
    • 歐洲溶酵素體貯積病藥物市場：按國家/地區分類
      • 德國
      • 英國
      • 法國
      • 俄羅斯
      • 西班牙
      • 意大利
      • 其他歐洲
  • 亞太地區
    • 亞太溶酵素體貯積症藥物市場：按國家/地區分類
      • 中國
      • 日本
      • 印度
      • 韓國
      • 新加坡
      • 馬來西亞
      • 其他亞太地區
  • LAMEA
    • LAMEA 溶酵素體貯積症藥物市場：按國家/地區分類
      • 巴西
      • 阿根廷
      • 阿聯酋
      • 沙特阿拉伯
      • 南非
      • 尼日利亞
      • 其他 LAMEA

第七章公司簡介

  • Merck & Co., Inc.
  • Johnson & Johnson（Janssen Global Services, LLC）
  • Eli Lilly And Company
  • Pfizer, Inc.
  • Takeda Pharmaceutical Company Limited
  • Sanofi S.A.
  • Novartis AG
  • AstraZeneca PLC（Alexion Pharmaceuticals, Inc.）
  • BioMarin Pharmaceutical Inc.
  • Sigilon Therapeutics, Inc.

The Global Lysosomal Disease Treatment Market size is expected to reach $11 billion by 2028, rising at a market growth of 6.3% CAGR during the forecast period.

Lysosomal diseases (LSDs) are a complex group of metabolic disorders that are often inherited in an autosomal recessive manner. There are currently 45 known diseases. They are caused by malfunctions in various lysosomal processes, most often by abnormalities in genes that produce catabolic enzymes responsible for the breakdown of macromolecules. As the faulty enzyme accumulates substrate, cell malfunction and clinical symptoms escalate.

Other types of lysosomal dysfunction that can lead to lysosomal storage include defects in post-translational processing of lysosomal enzymes, errors in enzyme trafficking or targeting, and dysfunction of non-enzymatic transmembrane and solubilize.

Lysosomal hydrolase mutations, which are implicated in the breakdown of cellular macromolecules, are the primary cause of LSDs, accounting for more than two-thirds of cases. As a result, there are many different types of lipids, glycogen, mucopolysaccharides, and glycoproteins among the storage products in LSDs that are biochemical in origin. The LSDs are all inherited as autosomal recessive characteristics, except the X-linked Fabry, Danon, and Hunter diseases.

The LSDs can affect the majority of organs, either alone or as part of a multisystem illness, and are clinically very heterogeneous. Even though lysosomal enzymes are housekeeping genes and expressed in the majority of cells, the tissues on which they act are distributed much less uniformly, and this determines which tissues in any individual are affected.

COVID-19 Impact Analysis

The COVID-19 public health crisis has affected almost every industry. The COVID-19 outbreak has caused a significant decrease in demand for the lysosomal disease treatment size of the market across several sectors, especially the health and pharmaceutical sector, as coronavirus crises sweep the globe and force healthcare providers to devote a large percentage of their funds to fighting COVID-19. The risk of infection was the primary factor contributing to the delays in treatment that patients with lysosomal storage disorder encountered in hospitals. The COVID-19 outbreak harms the market's value in 2022 and beyond because it will delay the development of the worldwide market for lysosomal disease treatments.

Market Growth Factor

Incidence of Lysosomal Disorders Are Rising

The primary driving forces in the enzyme replacement therapy market are the expanding research and development for lysosomal disease diagnosis and drug development for treatment. The increasing incidence of lysosomal disease will be a key factor contributing to the acceleration of the market's growth rate. According to a report published by the National Center for Biotechnology Information, the prevalence of Fabry disease in communities of white, male individuals ranged from 1:17,000 to 1:117,000 in January 2020. Atypical presentations were associated with around 1:6000-1:40,000 females and 1:1000-1:3000 males, whereas 1:22,000-1:40,000 males had the classic Fabry disease mutations.

Financial Incentives for Developing Orphan Drugs to Recoup R&D Expenses

The increases in healthcare spending, which helps to improve its infrastructure, is a crucial element affecting the market's growth rate for therapies for lysosomal diseases. The market dynamics will be further impacted by various government organizations' efforts to strengthen the healthcare infrastructure by boosting funding. Additionally, the market for lysosomal disease therapies will grow as a result of the rising acceptance rate of early diagnosis and the increasing number of government programs to raise awareness. Along with this, expanding government benevolent programs and an increase in disposable money would accelerate market expansion.

Market Restraining Factor

The Treatment of Stem Cells Is Fraught with Issues

Many of the issues that can arise soon after the transplant are caused by the bone marrow being destroyed just before it by drugs or radiation. Some may be unintended consequences of the conditioning procedures themselves. The patient can get support from the transplant team to manage side effects. Most can be addressed to make the patient feel better, and some can be prevented. This is not a comprehensive list, so please inform the physician or the transplant team of any issues or adjustments that experience.

Disease Type Outlook

Based on the Disease Type, the Lysosomal Disease Treatment Market is segmented into Gaucher's Diseases, Fabry Diseases, Pompe's Syndrome, Mucopolysaccharidosis, and Others. The Gaucher's disease segment acquired the highest revenue share in the lysosomal disease treatment market in 2021. It is due to the rising prevalence of Gaucher's disease is the main market growth driver. Additionally, this segment's growth is fueled by potent approved medications and new treatments that are under development.

Type of Therapy Outlook

On the basis of Type of Therapy, the Lysosomal Disease Treatment Market is divided into Enzyme Replacement Therapy, Stem Cell Therapy, Substrate Reduction Therapy, and Others. The stem cell therapy segment registered a substantial revenue share in the lysosomal disease treatment market in 2021. LSDs are a very appealing target for stem cell therapy due to the capacity to perform cross-correction through secretion-reuptake of lysosomal hydrolases, and allogeneic transplantation of bone marrow was the first specific therapeutic method to be applied to LSDs.

End User Outlook

By End-user, the Lysosomal Disease Treatment Market is bifurcated into Hospitals, Clinics, and Others. The hospital segment garnered the highest revenue share in the lysosomal disease treatment market in 2021. due to an increase in people seeking hospital care for lysosomal illnesses. In response to the rising demand for clinical practices to be streamlined cost-effectively, hospitals are using these technologies. A hospital is a facility with skilled medical staff, administrative staff, and medical equipment where people can receive medical care.

Regional Outlook

Region-wise, the Lysosomal Disease Treatment Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment acquired the largest revenue share in the lysosomal disease treatment market in 2021. Due to the lysosomal disease's high prevalence in North America. The development of new medical therapies, advancements in diagnostic technology, and growing public awareness of lysosomal disorders is fueling this market's expansion. Countries have used a variety of strategies that matched their particular needs to address this particular issue of high costs.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck & Co., Inc., Johnson & Johnson (Janssen Global Services, LLC), Eli Lilly And Company, Pfizer, Inc., Takeda Pharmaceutical Company Limited, Sanofi S.A., Novartis AG, AstraZeneca PLC (Alexion Pharmaceuticals, Inc.), BioMarin Pharmaceutical Inc. and Sigilon Therapeutics, Inc.

Scope of the Study

Market Segments covered in the Report:

By Disease Type

  • Gaucher's Diseases
  • Fabry Diseases
  • Mucopolysaccharidosis
  • Pompe's Syndrome
  • Others

By Type of Therapy

  • Enzyme Replacement Therapy
  • Substrate Reduction Therapy
  • Stem Cell Therapy
  • Others

By End User

  • Hospitals
  • Clinics
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Merck & Co., Inc.
  • Johnson & Johnson (Janssen Global Services, LLC)
  • Eli Lilly And Company
  • Pfizer, Inc.
  • Takeda Pharmaceutical Company Limited
  • Sanofi S.A.
  • Novartis AG
  • AstraZeneca PLC (Alexion Pharmaceuticals, Inc.)
  • BioMarin Pharmaceutical Inc.
  • Sigilon Therapeutics, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Lysosomal Disease Treatment Market, by Disease Type
    • 1.4.2 Global Lysosomal Disease Treatment Market, by Type of Therapy
    • 1.4.3 Global Lysosomal Disease Treatment Market, by End User
    • 1.4.4 Global Lysosomal Disease Treatment Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition & scenarios
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Lysosomal Disease Treatment Market by Disease Type

  • 3.1 Global Gaucher's Diseases Market by Region
  • 3.2 Global Fabry Diseases Market by Region
  • 3.3 Global Mucopolysaccharidosis Market by Region
  • 3.4 Global Pompe's Syndrome Market by Region
  • 3.5 Global Others Market by Region

Chapter 4. Global Lysosomal Disease Treatment Market by Type of Therapy

  • 4.1 Global Enzyme Replacement Therapy Market by Region
  • 4.2 Global Substrate Reduction Therapy Market by Region
  • 4.3 Global Stem Cell Therapy Market by Region
  • 4.4 Global Others Market by Region

Chapter 5. Global Lysosomal Disease Treatment Market by End User

  • 5.1 Global Hospitals Market by Region
  • 5.2 Global Clinics Market by Region
  • 5.3 Global Others Market by Region

Chapter 6. Global Lysosomal Disease Treatment Market by Region

  • 6.1 North America Lysosomal Disease Treatment Market
    • 6.1.1 North America Lysosomal Disease Treatment Market by Disease Type
      • 6.1.1.1 North America Gaucher's Diseases Market by Country
      • 6.1.1.2 North America Fabry Diseases Market by Country
      • 6.1.1.3 North America Mucopolysaccharidosis Market by Country
      • 6.1.1.4 North America Pompe's Syndrome Market by Country
      • 6.1.1.5 North America Others Market by Country
    • 6.1.2 North America Lysosomal Disease Treatment Market by Type of Therapy
      • 6.1.2.1 North America Enzyme Replacement Therapy Market by Country
      • 6.1.2.2 North America Substrate Reduction Therapy Market by Country
      • 6.1.2.3 North America Stem Cell Therapy Market by Country
      • 6.1.2.4 North America Others Market by Country
    • 6.1.3 North America Lysosomal Disease Treatment Market by End User
      • 6.1.3.1 North America Hospitals Market by Country
      • 6.1.3.2 North America Clinics Market by Country
      • 6.1.3.3 North America Others Market by Country
    • 6.1.4 North America Lysosomal Disease Treatment Market by Country
      • 6.1.4.1 US Lysosomal Disease Treatment Market
        • 6.1.4.1.1 US Lysosomal Disease Treatment Market by Disease Type
        • 6.1.4.1.2 US Lysosomal Disease Treatment Market by Type of Therapy
        • 6.1.4.1.3 US Lysosomal Disease Treatment Market by End User
      • 6.1.4.2 Canada Lysosomal Disease Treatment Market
        • 6.1.4.2.1 Canada Lysosomal Disease Treatment Market by Disease Type
        • 6.1.4.2.2 Canada Lysosomal Disease Treatment Market by Type of Therapy
        • 6.1.4.2.3 Canada Lysosomal Disease Treatment Market by End User
      • 6.1.4.3 Mexico Lysosomal Disease Treatment Market
        • 6.1.4.3.1 Mexico Lysosomal Disease Treatment Market by Disease Type
        • 6.1.4.3.2 Mexico Lysosomal Disease Treatment Market by Type of Therapy
        • 6.1.4.3.3 Mexico Lysosomal Disease Treatment Market by End User
      • 6.1.4.4 Rest of North America Lysosomal Disease Treatment Market
        • 6.1.4.4.1 Rest of North America Lysosomal Disease Treatment Market by Disease Type
        • 6.1.4.4.2 Rest of North America Lysosomal Disease Treatment Market by Type of Therapy
        • 6.1.4.4.3 Rest of North America Lysosomal Disease Treatment Market by End User
  • 6.2 Europe Lysosomal Disease Treatment Market
    • 6.2.1 Europe Lysosomal Disease Treatment Market by Disease Type
      • 6.2.1.1 Europe Gaucher's Diseases Market by Country
      • 6.2.1.2 Europe Fabry Diseases Market by Country
      • 6.2.1.3 Europe Mucopolysaccharidosis Market by Country
      • 6.2.1.4 Europe Pompe's Syndrome Market by Country
      • 6.2.1.5 Europe Others Market by Country
    • 6.2.2 Europe Lysosomal Disease Treatment Market by Type of Therapy
      • 6.2.2.1 Europe Enzyme Replacement Therapy Market by Country
      • 6.2.2.2 Europe Substrate Reduction Therapy Market by Country
      • 6.2.2.3 Europe Stem Cell Therapy Market by Country
      • 6.2.2.4 Europe Others Market by Country
    • 6.2.3 Europe Lysosomal Disease Treatment Market by End User
      • 6.2.3.1 Europe Hospitals Market by Country
      • 6.2.3.2 Europe Clinics Market by Country
      • 6.2.3.3 Europe Others Market by Country
    • 6.2.4 Europe Lysosomal Disease Treatment Market by Country
      • 6.2.4.1 Germany Lysosomal Disease Treatment Market
        • 6.2.4.1.1 Germany Lysosomal Disease Treatment Market by Disease Type
        • 6.2.4.1.2 Germany Lysosomal Disease Treatment Market by Type of Therapy
        • 6.2.4.1.3 Germany Lysosomal Disease Treatment Market by End User
      • 6.2.4.2 UK Lysosomal Disease Treatment Market
        • 6.2.4.2.1 UK Lysosomal Disease Treatment Market by Disease Type
        • 6.2.4.2.2 UK Lysosomal Disease Treatment Market by Type of Therapy
        • 6.2.4.2.3 UK Lysosomal Disease Treatment Market by End User
      • 6.2.4.3 France Lysosomal Disease Treatment Market
        • 6.2.4.3.1 France Lysosomal Disease Treatment Market by Disease Type
        • 6.2.4.3.2 France Lysosomal Disease Treatment Market by Type of Therapy
        • 6.2.4.3.3 France Lysosomal Disease Treatment Market by End User
      • 6.2.4.4 Russia Lysosomal Disease Treatment Market
        • 6.2.4.4.1 Russia Lysosomal Disease Treatment Market by Disease Type
        • 6.2.4.4.2 Russia Lysosomal Disease Treatment Market by Type of Therapy
        • 6.2.4.4.3 Russia Lysosomal Disease Treatment Market by End User
      • 6.2.4.5 Spain Lysosomal Disease Treatment Market
        • 6.2.4.5.1 Spain Lysosomal Disease Treatment Market by Disease Type
        • 6.2.4.5.2 Spain Lysosomal Disease Treatment Market by Type of Therapy
        • 6.2.4.5.3 Spain Lysosomal Disease Treatment Market by End User
      • 6.2.4.6 Italy Lysosomal Disease Treatment Market
        • 6.2.4.6.1 Italy Lysosomal Disease Treatment Market by Disease Type
        • 6.2.4.6.2 Italy Lysosomal Disease Treatment Market by Type of Therapy
        • 6.2.4.6.3 Italy Lysosomal Disease Treatment Market by End User
      • 6.2.4.7 Rest of Europe Lysosomal Disease Treatment Market
        • 6.2.4.7.1 Rest of Europe Lysosomal Disease Treatment Market by Disease Type
        • 6.2.4.7.2 Rest of Europe Lysosomal Disease Treatment Market by Type of Therapy
        • 6.2.4.7.3 Rest of Europe Lysosomal Disease Treatment Market by End User
  • 6.3 Asia Pacific Lysosomal Disease Treatment Market
    • 6.3.1 Asia Pacific Lysosomal Disease Treatment Market by Disease Type
      • 6.3.1.1 Asia Pacific Gaucher's Diseases Market by Country
      • 6.3.1.2 Asia Pacific Fabry Diseases Market by Country
      • 6.3.1.3 Asia Pacific Mucopolysaccharidosis Market by Country
      • 6.3.1.4 Asia Pacific Pompe's Syndrome Market by Country
      • 6.3.1.5 Asia Pacific Others Market by Country
    • 6.3.2 Asia Pacific Lysosomal Disease Treatment Market by Type of Therapy
      • 6.3.2.1 Asia Pacific Enzyme Replacement Therapy Market by Country
      • 6.3.2.2 Asia Pacific Substrate Reduction Therapy Market by Country
      • 6.3.2.3 Asia Pacific Stem Cell Therapy Market by Country
      • 6.3.2.4 Asia Pacific Others Market by Country
    • 6.3.3 Asia Pacific Lysosomal Disease Treatment Market by End User
      • 6.3.3.1 Asia Pacific Hospitals Market by Country
      • 6.3.3.2 Asia Pacific Clinics Market by Country
      • 6.3.3.3 Asia Pacific Others Market by Country
    • 6.3.4 Asia Pacific Lysosomal Disease Treatment Market by Country
      • 6.3.4.1 China Lysosomal Disease Treatment Market
        • 6.3.4.1.1 China Lysosomal Disease Treatment Market by Disease Type
        • 6.3.4.1.2 China Lysosomal Disease Treatment Market by Type of Therapy
        • 6.3.4.1.3 China Lysosomal Disease Treatment Market by End User
      • 6.3.4.2 Japan Lysosomal Disease Treatment Market
        • 6.3.4.2.1 Japan Lysosomal Disease Treatment Market by Disease Type
        • 6.3.4.2.2 Japan Lysosomal Disease Treatment Market by Type of Therapy
        • 6.3.4.2.3 Japan Lysosomal Disease Treatment Market by End User
      • 6.3.4.3 India Lysosomal Disease Treatment Market
        • 6.3.4.3.1 India Lysosomal Disease Treatment Market by Disease Type
        • 6.3.4.3.2 India Lysosomal Disease Treatment Market by Type of Therapy
        • 6.3.4.3.3 India Lysosomal Disease Treatment Market by End User
      • 6.3.4.4 South Korea Lysosomal Disease Treatment Market
        • 6.3.4.4.1 South Korea Lysosomal Disease Treatment Market by Disease Type
        • 6.3.4.4.2 South Korea Lysosomal Disease Treatment Market by Type of Therapy
        • 6.3.4.4.3 South Korea Lysosomal Disease Treatment Market by End User
      • 6.3.4.5 Singapore Lysosomal Disease Treatment Market
        • 6.3.4.5.1 Singapore Lysosomal Disease Treatment Market by Disease Type
        • 6.3.4.5.2 Singapore Lysosomal Disease Treatment Market by Type of Therapy
        • 6.3.4.5.3 Singapore Lysosomal Disease Treatment Market by End User
      • 6.3.4.6 Malaysia Lysosomal Disease Treatment Market
        • 6.3.4.6.1 Malaysia Lysosomal Disease Treatment Market by Disease Type
        • 6.3.4.6.2 Malaysia Lysosomal Disease Treatment Market by Type of Therapy
        • 6.3.4.6.3 Malaysia Lysosomal Disease Treatment Market by End User
      • 6.3.4.7 Rest of Asia Pacific Lysosomal Disease Treatment Market
        • 6.3.4.7.1 Rest of Asia Pacific Lysosomal Disease Treatment Market by Disease Type
        • 6.3.4.7.2 Rest of Asia Pacific Lysosomal Disease Treatment Market by Type of Therapy
        • 6.3.4.7.3 Rest of Asia Pacific Lysosomal Disease Treatment Market by End User
  • 6.4 LAMEA Lysosomal Disease Treatment Market
    • 6.4.1 LAMEA Lysosomal Disease Treatment Market by Disease Type
      • 6.4.1.1 LAMEA Gaucher's Diseases Market by Country
      • 6.4.1.2 LAMEA Fabry Diseases Market by Country
      • 6.4.1.3 LAMEA Mucopolysaccharidosis Market by Country
      • 6.4.1.4 LAMEA Pompe's Syndrome Market by Country
      • 6.4.1.5 LAMEA Others Market by Country
    • 6.4.2 LAMEA Lysosomal Disease Treatment Market by Type of Therapy
      • 6.4.2.1 LAMEA Enzyme Replacement Therapy Market by Country
      • 6.4.2.2 LAMEA Substrate Reduction Therapy Market by Country
      • 6.4.2.3 LAMEA Stem Cell Therapy Market by Country
      • 6.4.2.4 LAMEA Others Market by Country
    • 6.4.3 LAMEA Lysosomal Disease Treatment Market by End User
      • 6.4.3.1 LAMEA Hospitals Market by Country
      • 6.4.3.2 LAMEA Clinics Market by Country
      • 6.4.3.3 LAMEA Others Market by Country
    • 6.4.4 LAMEA Lysosomal Disease Treatment Market by Country
      • 6.4.4.1 Brazil Lysosomal Disease Treatment Market
        • 6.4.4.1.1 Brazil Lysosomal Disease Treatment Market by Disease Type
        • 6.4.4.1.2 Brazil Lysosomal Disease Treatment Market by Type of Therapy
        • 6.4.4.1.3 Brazil Lysosomal Disease Treatment Market by End User
      • 6.4.4.2 Argentina Lysosomal Disease Treatment Market
        • 6.4.4.2.1 Argentina Lysosomal Disease Treatment Market by Disease Type
        • 6.4.4.2.2 Argentina Lysosomal Disease Treatment Market by Type of Therapy
        • 6.4.4.2.3 Argentina Lysosomal Disease Treatment Market by End User
      • 6.4.4.3 UAE Lysosomal Disease Treatment Market
        • 6.4.4.3.1 UAE Lysosomal Disease Treatment Market by Disease Type
        • 6.4.4.3.2 UAE Lysosomal Disease Treatment Market by Type of Therapy
        • 6.4.4.3.3 UAE Lysosomal Disease Treatment Market by End User
      • 6.4.4.4 Saudi Arabia Lysosomal Disease Treatment Market
        • 6.4.4.4.1 Saudi Arabia Lysosomal Disease Treatment Market by Disease Type
        • 6.4.4.4.2 Saudi Arabia Lysosomal Disease Treatment Market by Type of Therapy
        • 6.4.4.4.3 Saudi Arabia Lysosomal Disease Treatment Market by End User
      • 6.4.4.5 South Africa Lysosomal Disease Treatment Market
        • 6.4.4.5.1 South Africa Lysosomal Disease Treatment Market by Disease Type
        • 6.4.4.5.2 South Africa Lysosomal Disease Treatment Market by Type of Therapy
        • 6.4.4.5.3 South Africa Lysosomal Disease Treatment Market by End User
      • 6.4.4.6 Nigeria Lysosomal Disease Treatment Market
        • 6.4.4.6.1 Nigeria Lysosomal Disease Treatment Market by Disease Type
        • 6.4.4.6.2 Nigeria Lysosomal Disease Treatment Market by Type of Therapy
        • 6.4.4.6.3 Nigeria Lysosomal Disease Treatment Market by End User
      • 6.4.4.7 Rest of LAMEA Lysosomal Disease Treatment Market
        • 6.4.4.7.1 Rest of LAMEA Lysosomal Disease Treatment Market by Disease Type
        • 6.4.4.7.2 Rest of LAMEA Lysosomal Disease Treatment Market by Type of Therapy
        • 6.4.4.7.3 Rest of LAMEA Lysosomal Disease Treatment Market by End User

Chapter 7. Company Profiles

  • 7.1 Merck & Co., Inc.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expenses
  • 7.2 Johnson & Johnson (Janssen Global Services, LLC)
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Segmental &Regional Analysis
    • 7.2.4 Research & Development Expenses
  • 7.3 Eli Lilly And Company
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Regional Analysis
    • 7.3.4 Research & Development Expenses
    • 7.3.5 Recent strategies and developments:
      • 7.3.5.1 Acquisition and Mergers:
  • 7.4 Pfizer, Inc.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Regional & Segmental Analysis
    • 7.4.4 Research & Development Expense
    • 7.4.5 Recent strategies and developments:
      • 7.4.5.1 Partnerships, Collaborations, and Agreements:
  • 7.5 Takeda Pharmaceutical Company Limited
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Regional Analysis
    • 7.5.4 Research & Development Expense
  • 7.6 Sanofi S.A.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expense
    • 7.6.5 Recent strategies and developments:
      • 7.6.5.1 Approvals and Trials:
  • 7.7 Novartis AG
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental and Regional Analysis
    • 7.7.4 Research & Development Expense
  • 7.8 AstraZeneca PLC (Alexion Pharmaceuticals, Inc.)
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Regional Analysis
    • 7.8.4 Research & Development Expenses
  • 7.9 BioMarin Pharmaceutical Inc.
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Regional Analysis
    • 7.9.4 Research & Development Expenses
    • 7.9.5 Recent strategies and developments:
      • 7.9.5.1 Approvals and Trials:
  • 7.10. Sigilon Therapeutics, Inc.
    • 7.10.1 Company Overview
    • 7.10.2 Financial Analysis
    • 7.10.3 Research & Development Expenses

LIST OF TABLES

  • TABLE 1 Global Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 2 Global Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 3 Global Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 4 Global Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 5 Global Gaucher's Diseases Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Gaucher's Diseases Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Fabry Diseases Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Fabry Diseases Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Mucopolysaccharidosis Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Mucopolysaccharidosis Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Pompe's Syndrome Market by Region, 2018 - 2021, USD Million
  • TABLE 12 Global Pompe's Syndrome Market by Region, 2022 - 2028, USD Million
  • TABLE 13 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 16 Global Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 17 Global Enzyme Replacement Therapy Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Enzyme Replacement Therapy Market by Region, 2022 - 2028, USD Million
  • TABLE 19 Global Substrate Reduction Therapy Market by Region, 2018 - 2021, USD Million
  • TABLE 20 Global Substrate Reduction Therapy Market by Region, 2022 - 2028, USD Million
  • TABLE 21 Global Stem Cell Therapy Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Stem Cell Therapy Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 25 Global Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 26 Global Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 27 Global Hospitals Market by Region, 2018 - 2021, USD Million
  • TABLE 28 Global Hospitals Market by Region, 2022 - 2028, USD Million
  • TABLE 29 Global Clinics Market by Region, 2018 - 2021, USD Million
  • TABLE 30 Global Clinics Market by Region, 2022 - 2028, USD Million
  • TABLE 31 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 32 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 33 Global Lysosomal Disease Treatment Market by Region, 2018 - 2021, USD Million
  • TABLE 34 Global Lysosomal Disease Treatment Market by Region, 2022 - 2028, USD Million
  • TABLE 35 North America Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 36 North America Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 37 North America Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 38 North America Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 39 North America Gaucher's Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 40 North America Gaucher's Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 41 North America Fabry Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 42 North America Fabry Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 43 North America Mucopolysaccharidosis Market by Country, 2018 - 2021, USD Million
  • TABLE 44 North America Mucopolysaccharidosis Market by Country, 2022 - 2028, USD Million
  • TABLE 45 North America Pompe's Syndrome Market by Country, 2018 - 2021, USD Million
  • TABLE 46 North America Pompe's Syndrome Market by Country, 2022 - 2028, USD Million
  • TABLE 47 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 48 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 49 North America Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 50 North America Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 51 North America Enzyme Replacement Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 52 North America Enzyme Replacement Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 53 North America Substrate Reduction Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 54 North America Substrate Reduction Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 55 North America Stem Cell Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 56 North America Stem Cell Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 57 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 58 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 59 North America Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 60 North America Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 61 North America Hospitals Market by Country, 2018 - 2021, USD Million
  • TABLE 62 North America Hospitals Market by Country, 2022 - 2028, USD Million
  • TABLE 63 North America Clinics Market by Country, 2018 - 2021, USD Million
  • TABLE 64 North America Clinics Market by Country, 2022 - 2028, USD Million
  • TABLE 65 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 66 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 67 North America Lysosomal Disease Treatment Market by Country, 2018 - 2021, USD Million
  • TABLE 68 North America Lysosomal Disease Treatment Market by Country, 2022 - 2028, USD Million
  • TABLE 69 US Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 70 US Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 71 US Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 72 US Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 73 US Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 74 US Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 75 US Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 76 US Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 77 Canada Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 78 Canada Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 79 Canada Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 80 Canada Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 81 Canada Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 82 Canada Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 83 Canada Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 84 Canada Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 85 Mexico Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 86 Mexico Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 87 Mexico Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 88 Mexico Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 89 Mexico Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 90 Mexico Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 91 Mexico Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 92 Mexico Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 93 Rest of North America Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 94 Rest of North America Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 95 Rest of North America Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 96 Rest of North America Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 97 Rest of North America Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 98 Rest of North America Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 99 Rest of North America Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 100 Rest of North America Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 101 Europe Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 102 Europe Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 103 Europe Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 104 Europe Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 105 Europe Gaucher's Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 106 Europe Gaucher's Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 107 Europe Fabry Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 108 Europe Fabry Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 109 Europe Mucopolysaccharidosis Market by Country, 2018 - 2021, USD Million
  • TABLE 110 Europe Mucopolysaccharidosis Market by Country, 2022 - 2028, USD Million
  • TABLE 111 Europe Pompe's Syndrome Market by Country, 2018 - 2021, USD Million
  • TABLE 112 Europe Pompe's Syndrome Market by Country, 2022 - 2028, USD Million
  • TABLE 113 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 114 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 115 Europe Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 116 Europe Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 117 Europe Enzyme Replacement Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 118 Europe Enzyme Replacement Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 119 Europe Substrate Reduction Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 120 Europe Substrate Reduction Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 121 Europe Stem Cell Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 122 Europe Stem Cell Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 123 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 124 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 125 Europe Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 126 Europe Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 127 Europe Hospitals Market by Country, 2018 - 2021, USD Million
  • TABLE 128 Europe Hospitals Market by Country, 2022 - 2028, USD Million
  • TABLE 129 Europe Clinics Market by Country, 2018 - 2021, USD Million
  • TABLE 130 Europe Clinics Market by Country, 2022 - 2028, USD Million
  • TABLE 131 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 132 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 133 Europe Lysosomal Disease Treatment Market by Country, 2018 - 2021, USD Million
  • TABLE 134 Europe Lysosomal Disease Treatment Market by Country, 2022 - 2028, USD Million
  • TABLE 135 Germany Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 136 Germany Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 137 Germany Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 138 Germany Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 139 Germany Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 140 Germany Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 141 Germany Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 142 Germany Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 143 UK Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 144 UK Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 145 UK Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 146 UK Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 147 UK Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 148 UK Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 149 UK Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 150 UK Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 151 France Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 152 France Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 153 France Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 154 France Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 155 France Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 156 France Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 157 France Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 158 France Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 159 Russia Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 160 Russia Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 161 Russia Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 162 Russia Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 163 Russia Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 164 Russia Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 165 Russia Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 166 Russia Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 167 Spain Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 168 Spain Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 169 Spain Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 170 Spain Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 171 Spain Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 172 Spain Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 173 Spain Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 174 Spain Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 175 Italy Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 176 Italy Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 177 Italy Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 178 Italy Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 179 Italy Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 180 Italy Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 181 Italy Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 182 Italy Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 183 Rest of Europe Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 184 Rest of Europe Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 185 Rest of Europe Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 186 Rest of Europe Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 187 Rest of Europe Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 188 Rest of Europe Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 189 Rest of Europe Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 190 Rest of Europe Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 191 Asia Pacific Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 192 Asia Pacific Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 193 Asia Pacific Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 194 Asia Pacific Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 195 Asia Pacific Gaucher's Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 196 Asia Pacific Gaucher's Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 197 Asia Pacific Fabry Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 198 Asia Pacific Fabry Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 199 Asia Pacific Mucopolysaccharidosis Market by Country, 2018 - 2021, USD Million
  • TABLE 200 Asia Pacific Mucopolysaccharidosis Market by Country, 2022 - 2028, USD Million
  • TABLE 201 Asia Pacific Pompe's Syndrome Market by Country, 2018 - 2021, USD Million
  • TABLE 202 Asia Pacific Pompe's Syndrome Market by Country, 2022 - 2028, USD Million
  • TABLE 203 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 204 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 205 Asia Pacific Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 206 Asia Pacific Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 207 Asia Pacific Enzyme Replacement Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 208 Asia Pacific Enzyme Replacement Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 209 Asia Pacific Substrate Reduction Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 210 Asia Pacific Substrate Reduction Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 211 Asia Pacific Stem Cell Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 212 Asia Pacific Stem Cell Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 213 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 214 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 215 Asia Pacific Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 216 Asia Pacific Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 217 Asia Pacific Hospitals Market by Country, 2018 - 2021, USD Million
  • TABLE 218 Asia Pacific Hospitals Market by Country, 2022 - 2028, USD Million
  • TABLE 219 Asia Pacific Clinics Market by Country, 2018 - 2021, USD Million
  • TABLE 220 Asia Pacific Clinics Market by Country, 2022 - 2028, USD Million
  • TABLE 221 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 222 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 223 Asia Pacific Lysosomal Disease Treatment Market by Country, 2018 - 2021, USD Million
  • TABLE 224 Asia Pacific Lysosomal Disease Treatment Market by Country, 2022 - 2028, USD Million
  • TABLE 225 China Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 226 China Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 227 China Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 228 China Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 229 China Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 230 China Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 231 China Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 232 China Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 233 Japan Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 234 Japan Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 235 Japan Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 236 Japan Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 237 Japan Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 238 Japan Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 239 Japan Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 240 Japan Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 241 India Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 242 India Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 243 India Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 244 India Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 245 India Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 246 India Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 247 India Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 248 India Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 249 South Korea Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 250 South Korea Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 251 South Korea Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 252 South Korea Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 253 South Korea Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 254 South Korea Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 255 South Korea Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 256 South Korea Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 257 Singapore Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 258 Singapore Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 259 Singapore Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 260 Singapore Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 261 Singapore Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 262 Singapore Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 263 Singapore Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 264 Singapore Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 265 Malaysia Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 266 Malaysia Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 267 Malaysia Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 268 Malaysia Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 269 Malaysia Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 270 Malaysia Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 271 Malaysia Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 272 Malaysia Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 273 Rest of Asia Pacific Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 274 Rest of Asia Pacific Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 275 Rest of Asia Pacific Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 276 Rest of Asia Pacific Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 277 Rest of Asia Pacific Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 278 Rest of Asia Pacific Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 279 Rest of Asia Pacific Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 280 Rest of Asia Pacific Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 281 LAMEA Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 282 LAMEA Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 283 LAMEA Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 284 LAMEA Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 285 LAMEA Gaucher's Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 286 LAMEA Gaucher's Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 287 LAMEA Fabry Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 288 LAMEA Fabry Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 289 LAMEA Mucopolysaccharidosis Market by Country, 2018 - 2021, USD Million
  • TABLE 290 LAMEA Mucopolysaccharidosis Market by Country, 2022 - 2028, USD Million
  • TABLE 291 LAMEA Pompe's Syndrome Market by Country, 2018 - 2021, USD Million
  • TABLE 292 LAMEA Pompe's Syndrome Market by Country, 2022 - 2028, USD Million
  • TABLE 293 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 294 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 295 LAMEA Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 296 LAMEA Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 297 LAMEA Enzyme Replacement Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 298 LAMEA Enzyme Replacement Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 299 LAMEA Substrate Reduction Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 300 LAMEA Substrate Reduction Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 301 LAMEA Stem Cell Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 302 LAMEA Stem Cell Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 303 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 304 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 305 LAMEA Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 306 LAMEA Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 307 LAMEA Hospitals Market by Country, 2018 - 2021, USD Million
  • TABLE 308 LAMEA Hospitals Market by Country, 2022 - 2028, USD Million
  • TABLE 309 LAMEA Clinics Market by Country, 2018 - 2021, USD Million
  • TABLE 310 LAMEA Clinics Market by Country, 2022 - 2028, USD Million
  • TABLE 311 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 312 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 313 LAMEA Lysosomal Disease Treatment Market by Country, 2018 - 2021, USD Million
  • TABLE 314 LAMEA Lysosomal Disease Treatment Market by Country, 2022 - 2028, USD Million
  • TABLE 315 Brazil Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 316 Brazil Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 317 Brazil Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 318 Brazil Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 319 Brazil Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 320 Brazil Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 321 Brazil Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 322 Brazil Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 323 Argentina Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 324 Argentina Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 325 Argentina Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 326 Argentina Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 327 Argentina Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 328 Argentina Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 329 Argentina Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 330 Argentina Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 331 UAE Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 332 UAE Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 333 UAE Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 334 UAE Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 335 UAE Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 336 UAE Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 337 UAE Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 338 UAE Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 339 Saudi Arabia Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 340 Saudi Arabia Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 341 Saudi Arabia Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 342 Saudi Arabia Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 343 Saudi Arabia Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 344 Saudi Arabia Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 345 Saudi Arabia Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 346 Saudi Arabia Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 347 South Africa Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 348 South Africa Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 349 South Africa Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 350 South Africa Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 351 South Africa Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 352 South Africa Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 353 South Africa Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 354 South Africa Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 355 Nigeria Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 356 Nigeria Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 357 Nigeria Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 358 Nigeria Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 359 Nigeria Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 360 Nigeria Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 361 Nigeria Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 362 Nigeria Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 363 Rest of LAMEA Lysosomal Disease Treatment Market, 2018 - 2021, USD Million
  • TABLE 364 Rest of LAMEA Lysosomal Disease Treatment Market, 2022 - 2028, USD Million
  • TABLE 365 Rest of LAMEA Lysosomal Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
  • TABLE 366 Rest of LAMEA Lysosomal Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
  • TABLE 367 Rest of LAMEA Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2021, USD Million
  • TABLE 368 Rest of LAMEA Lysosomal Disease Treatment Market by Type of Therapy, 2022 - 2028, USD Million
  • TABLE 369 Rest of LAMEA Lysosomal Disease Treatment Market by End User, 2018 - 2021, USD Million
  • TABLE 370 Rest of LAMEA Lysosomal Disease Treatment Market by End User, 2022 - 2028, USD Million
  • TABLE 371 KEY INFORMATION - MERCK & CO., INC.
  • TABLE 372 Key information -Johnson & Johnson
  • TABLE 373 Key Information - Eli Lilly And Company
  • TABLE 374 Key Information - Pfizer, Inc.
  • TABLE 375 Key Information - Takeda Pharmaceutical Company Limited
  • TABLE 376 Key Information - Sanofi S.A.
  • TABLE 377 Key Information - Novartis AG
  • TABLE 378 KEY INFORMATION - ASTRAZENECA PLC
  • TABLE 379 Key Information - BioMarin Pharmaceutical Inc.
  • TABLE 380 Key Information - Sigilon Therapeutics, Inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Lysosomal Disease Treatment Market Share by Disease Type, 2021
  • FIG 3 Global Lysosomal Disease Treatment Market Share by Disease Type, 2028
  • FIG 4 Global Lysosomal Disease Treatment Market by Disease Type, 2018 - 2028, USD Million
  • FIG 5 Global Lysosomal Disease Treatment Market Share by Type of Therapy, 2021
  • FIG 6 Global Lysosomal Disease Treatment Market Share by Type of Therapy, 2028
  • FIG 7 Global Lysosomal Disease Treatment Market by Type of Therapy, 2018 - 2028, USD Million
  • FIG 8 Global Lysosomal Disease Treatment Market Share by End User, 2021
  • FIG 9 Global Lysosomal Disease Treatment Market Share by End User, 2028
  • FIG 10 Global Lysosomal Disease Treatment Market by End User, 2018 - 2028, USD Million
  • FIG 11 Global Lysosomal Disease Treatment Market Share by Region, 2021
  • FIG 12 Global Lysosomal Disease Treatment Market Share by Region, 2028
  • FIG 13 Global Lysosomal Disease Treatment Market by Region, 2018 - 2028, USD Million